REVLIMID caps 2.5 mg 21 pce
7680577120061
CH-57712
L04AX04
07.16.4.
Reimbursement limitations:
REVLIMID.08
REVLIMID en association avec l’élotuzumab et la dexaméthasone
Après accord de la prise en charge …
1 / 2
google
Details
- Product number
- 5771208
- CPT
- -
- Packaging group
- 21
- Unit
- Kapsel(n)
- Composition
- lenalidomidum 2.5 mg, lactosum 73.5 mg, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium 0.2 mg, magnesii stearas, Kapselhülle: gelatina, E 171, E 172 (flavum), E 132, Drucktinte: lacca, propylenglycolum, E 172 (nigrum), kalii hydroxidum, pro capsula.
Articles (1)
REVLIMID 2.5 mg, Hartkapseln
Kapseln
21
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
2.5 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
73.5 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.2 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FNIDK |
|
(N/A)
|
- | Substance | FTODK |
|
(N/A)
|
- | Substance | FIMDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration) |
|
(N/A)
|
- | Substance | FTODK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 2416.00
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/06/2017
Authorization holder
Bristol-Myers Squibb SA
6312 Steinhausen
Authorization information
- Swissmedic authorization number
- 57712
- Drug name
- REVLIMID, Hartkapseln
- Galenic form
- KAHA
- ATC Code
- L04AX04
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 29/08/2007
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.4.
- Domain
- Human medicine
Packaging details
- Description (FR)
- REVLIMID caps 2.5 mg 21 pce
- Description (DE)
- REVLIMID Kaps 2.5 mg 21 Stk
- Market launch
- 28/06/2016
- Narcotic (BTM)
- No